Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mankind Pharma Ltd. ( (IN:MANKIND) ) has provided an update.
Mankind Pharma Ltd. has announced its participation in the upcoming Jefferies 4th India Forum, scheduled for September 17, 2025, in Gurugram. The event will include one-on-one and group meetings, allowing the company’s management to engage with investors. This participation underscores Mankind Pharma’s proactive approach to investor relations and its commitment to transparency, although no unpublished price-sensitive information will be disclosed during the conference.
More about Mankind Pharma Ltd.
Mankind Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its commitment to providing affordable and quality healthcare solutions, catering to both domestic and international markets.
Average Trading Volume: 19,238
Technical Sentiment Signal: Strong Buy
Current Market Cap: 1053.2B INR
For an in-depth examination of MANKIND stock, go to TipRanks’ Overview page.